Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies.
Wechsler ME, Brusselle G, Virchow JC, Bourdin A, Kostikas K, Llanos JP, Roseti SL, Ambrose CS, Hunter G, Jackson DJ, Castro M, Lugogo N, Pavord ID, Martin N, Brightling CE. Wechsler ME, et al. Among authors: ambrose cs. Eur Respir J. 2024 Sep 26:2400316. doi: 10.1183/13993003.00316-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39326921 Free article.
Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from DESTINATION.
Wechsler ME, Stolz D, Lugogo NL, Caveney S, Almqvist G, Bednarczyk A, Kotalik A, Chandarana S, Ambrose CS. Wechsler ME, et al. Among authors: ambrose cs. J Allergy Clin Immunol Pract. 2024 Nov;12(11):3128-3131.e2. doi: 10.1016/j.jaip.2024.08.008. Epub 2024 Aug 8. J Allergy Clin Immunol Pract. 2024. PMID: 39127103 Free article. No abstract available.
Biologic outcomes in U.S. Hispanic and Black patients with severe asthma.
Trevor J, Moore WC, Lugogo N, Ledford DK, Mackie A, Carstens D, Parada NA, Ambrose CS. Trevor J, et al. Among authors: ambrose cs. J Allergy Clin Immunol Pract. 2024 Oct;12(10):2844-2846.e1. doi: 10.1016/j.jaip.2024.06.020. Epub 2024 Jun 18. J Allergy Clin Immunol Pract. 2024. PMID: 38901615 Free article. No abstract available.
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study.
Carr TF, Moore WC, Kraft M, Brusselle G, Castro M, Chupp GL, Wechsler ME, Hunter G, Lindsley AW, Llanos JP, Burke LK, Chandarana S, Ambrose CS. Carr TF, et al. Among authors: ambrose cs. Adv Ther. 2024 Jul;41(7):2978-2990. doi: 10.1007/s12325-024-02889-8. Epub 2024 May 27. Adv Ther. 2024. PMID: 38802635 Free PMC article. Clinical Trial.
144 results